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Background and purpose   Dual-energy X-ray absorptiometry 
(DXA) analysis of the 7 periprosthetic Gruen zones is the most 
commonly used protocol to evaluate bone remodeling after the 
implantation of conventional femoral stems. We assessed the value 
of DXA after cementless primary total hip arthroplasty (THA)   
by comparing the effect of progressive shortening of the stem of 
two femoral implants on periprosthetic bone remodeling using a 
specifically developed protocol of analysis with 5 periprosthetic 
regions of interest (ROIs). 
Patients and methods   Bone mineral density (BMD) was evalu-
ated in 37 patients in the plateau stage, 3 years after THA. Two 
femoral implants featuring conceptually new designs and surgical 
technique were tested: types 1 and 2, characterized by extremely 
short stem and virtual absence of distal stem, respectively. 
Results   We found that progressive shortening of the femoral 
stem produces more proximal loading, which effectively preserves 
metaphyseal bone stock and increases periprosthetic BMD in the 
medial ROIs over time. In the type 2 group, higher absolute BMD 
values were observed in medial ROIs 4 and 5. No differences were 
found in ROIs 1, 2, and 3.
Interpretation     This  study  shows  the  flexibility  of  DXA  in 
adapting the protocol of periprosthetic analysis to the specific 
requirements of new implant designs, and it shows its high sensi-
tivity in evaluation of the biological response of bone to changes 
in implant shape.

Many  factors  may  affect  bone  remodeling  after  total  hip 
arthroplasty (THA). The stem geometry is believed to play 
an important role in the load transfer to the femur and, con-
sequently,  in  femoral  remodeling  (Hua  and  Walker  1995, 
Aamodt et al. 2001). It has been reported that a proximal-load-
ing device with extended metaphyseal geometry (lateral flare) 
preserves bone mass and increases periprosthetic bone stock 
(Leali and Fetto 2004), and that changes in the pattern of prox-
imal loading stimulate the formation of new bone trabeculae, 
which stream up to the level of the lateral flare (Walker et al. 
1999). Radiographic studies (Leali et al. 2002) and biome-
chanical tests (Walker et al. 1999, Kim et al. 2001, Westphal 
et al. 2006b) have confirmed that this kind of proximal geom-
etry provides effective initial and long-term stability, suggest-
ing that stems could be made shorter than designs that do not 
incorporate the lateral flare feature. Following this philosophy, 
an original custom-made ultra-short femoral stem with exten-
sive proximal load transfer was developed (type 1). The shape 
of  this  new  component  has  two  prominent  and  innovative 
features. The first is the marked reduction of the diaphyseal 
stem. The second is the presence of a well-defined lateral flare 
intended to conform to the lateral femoral endosteal surface. 
Based on the initially good performance of this new prosthe-
sis, the implant design was modified further, with an almost 
complete absence of the diaphyseal stem (type 2) (Santori et 
al. 2006a, b, c). In the last 25 years, there has been increas-
ing  interest  in  bone  densitometry  measurements  because 
periprosthetic measurements may allow the detection of bone 
remodeling that cannot otherwise be observed due to the lim-
ited sensitivity of conventional radiographs (Mirsky and Ein-
horn 1998). Due to improvements in software and technology, 
dual-energy X-ray absorptiometry (DXA) provides accurate 
measurement of total and regional periprosthetic bone min-
eral density (BMD) after THA (Trevisan et al. 1993, Mirsky 
and Einhorn 1998, Spittlehouse et al. 1998, Venesmaa et al. 
2001). This method has been shown to be useful in evaluation 
of the redistribution of mechanical forces around the hip joint 
following implantation of a prosthesis, and in assessment of 292  Acta Orthopaedica 2009; 80 (3): 291–297
how the proximal femur remodels around the implant (Brod-
ner et al. 2004). The efficacy of DXA in the evaluation of bone 
remodeling patterns associated with different stem geometries 
has also been reported (Gibbons et al. 1997, Spittlehouse et al. 
1998, Albanese et al. 2006).
We assessed the value of periprosthetic DXA in the bone 
remodeling plateau phase 3 years after THA using a 5-regions 




All 37 consecutive patients who had received either a type 
1 or a type 2 custom-made implant 3 years previously were 
included in this observational study. Patients were allocated 
into 2 consecutive groups. In the first group, the earlier devel-
oped design (type 1) was used, while in the second group the 
latest developed design (type 2) was implanted. The inclusion 
criteria were the year of operation and the diagnosis of hip 
osteoarthritis. Patients who were post-menopausal, who were 
markedly overweight or underweight, or who had a history of 
previous surgeries on the same hip, femoral fractures, meta-
bolic bone diseases, use of steroids or other drugs affecting 
bone metabolism, or intraoperative cracks were excluded from 
the study. All participants gave written informed consent to 
have 4 DXA examinations and to be included in the study, 
which was approved by the local Ethics Committee of Sapi-
enza University of Rome (31 May 2006, no. 5.6).
Study protocol 
Two  slightly  different  new  anatomical  models  of  design 
were tested: the first model (type 1; Stanmore Orthopaedics, 
Stanmore, UK) was fully coated and featured an extremely 
short distal stem, which never extended more than 3 cm 
below the lesser trochanter (n = 16). The tip of the second 
model (type 2; DePuy International Ltd., Leeds, UK) never 
extended below the lesser trochanter (n = 21). Both models 
were cementless and had a large lateral flare (Figures 1 and 
2). Preoperatively, each patient underwent a CT examina-
tion of the affected hip and a custom-made implant was spe-
cifically manufactured for each patient. The same surgeon 
(FSS) performed all operations in both study groups using 
the operative technique previously described by Santori et 
al. (2006c). At the time of the operation, the surgeon was 
provided  with  a  single  customized  implant  and  a  single 
corresponding broach. Standard radiographs were taken of 
all patients at the time of surgery and, postoperatively, at 
1, 6, and 12 months, and annually thereafter as previously 
described (Santori et al. 2006a). The occurrence of stem 
subsidence  and  the  appearance  of  radiolucent  lines  were 
recorded. A deviation greater than 2° from the longitudinal 
femoral axis was rated as either a varus or a valgus malposi-
tioning. Clinical assessments were done using the Harris hip 
score. Periarticular calcifications were rated according to 
Brooker et al. (1973). All patients underwent partial weight 
bearing for 6 weeks and had a 3-month postoperative reha-
bilitation supervised by a physiotherapist. The height (cm) 
and weight (kg) of patients were measured.
Figure 1. Type 1 custom-made femoral implant featuring an extremely 
short distal stem. DXA images of the proximal femoral periprosthetic 
analysis with 5 regions of interest (R1–R5).
Figure 2. Type 2 custom-made femoral implant featuring an almost 
complete absence of the stem. DXA images of the proximal femoral 
periprosthetic analysis with 5 regions of interest (R1–R5).Acta Orthopaedica 2009; 80 (3): 291–297  293
DXA technique and image analysis
DXA scans were performed using a Hologic QDR 4500-A 
device (Hologic Inc., Waltham, MA). The BMD (g/cm2) of 
the operated hip was measured using the “metal-removal hip” 
scanning mode. This mode has a higher resolution than the 
standard mode, giving a point resolution of 0.06 mm and a 
line spacing of 0.11 mm. The images were analyzed using 
the dedicated Windows analysis software (version 11.2). The 
patients were placed in supine position with the affected leg 
in slight internal rotation. The foot was secured in the Hologic 
foot positioning device in order to obtain reproducible rota-
tion in all patients to limit measurement errors, since it has 
been demonstrated that rotation influences the BMD (Cohen 
and Rushton 1995, Mortimer et al. 1996, Martini et al. 2000). 
Due to the distinctive geometry of type 1 and type 2 implants 
featuring an almost complete absence of the stem, the conven-
tional Gruen’s zones were reduced from 7 to 5 (the conven-
tional Gruen’s zones 3 and 5 were eliminated). Thus, a 5-ROI 
protocol of analysis was developed (Figures 1 and 2). 
The periprosthetic protocol of analysis was defined for the 
first patient to be examined with type 2 implant, then recorded 
and applied to all subsequent examinations in both groups in 
order to ensure an identical area for each ROI in both groups. 
The template of the protocol of analysis was neither increased 
nor decreased proportionally to the size of the implants and 
the size of the femur. In this protocol, the length of the implant 
was divided into 2 parts and subdivided into 2 lateral, 2 medial, 
and 1 inferior ROI. The 5 ROIs described in the protocol were 
defined as follows. ROI 1 (greater trochanter) includes the 
greater  trochanter  and  starts  from  the  ideal  horizontal  line 
drawn from the center of the lesser trochanter; ROI 2 (lateral) 
starts from the inferior edge of ROI 1 and ends at the tip of the 
implant; ROI 3 (below the tip) has the same height as ROI 2; 
ROI 4 (medial) has same bony landmarks and height as ROI 2; 
ROI 5 (calcar) includes the calcar and starts from the superior 
edge of ROI 4.
In order to compare the periprosthetic ROIs with the con-
tralateral unoperated hip, the scan window was automatically 
reflected on the contralateral side and then adjusted. The  BMD 
percentage of the contralateral, unoperated hip was calculated 
for each ROI as follows: (BMD of operated hip / BMD of 
unoperated hip) × 100. 
The amount of BMD was recorded for each ROI indepen-
dently in both hips. The overall BMD was summarized in the 
ROI’s net average (NETAVG). To evaluate the influence of 
possible preferential weight bearing upon BMD after surgery, 
or individual differences in BMD, the contralateral proximal 
femur (total hip) and lumbar spine (L1-L4) were also mea-
sured in all participants.
DXA precision was assessed on 15 subjects with unilateral 
THA (6 women and 9 men; mean age 53 (31–74) years). All 
subjects underwent sequential DXA examinations of the peri-
prosthetic hip, the contralateral unoperated hip, the lumbar 
spine, and the proximal femur—taken on the same day and 
measured twice, with repositioning between scans. Precision 
error was expressed as the coefficient of variation percentage 
(CV%). The CV% was calculated according to Aldinger et al. 
(2003). The precision (Table 1) was consistent with the lit-
erature (Aldinger et al. 2003, Shetty et al. 2006). The preci-
sion of lumbar spine and proximal femur was 1.2% and 1.3%. 
Additional quality controls were done every morning for the 
DXA equipment according to the manufacturer’s guidelines, 
to verify the stability of the system, and did not show any shift 
or drift during the entire study period. The device used in our 
study was therefore characterized as stable. The same observer 
(CVA) analyzed all DXA examinations.
Statistics
A Student’s t-test was used to test the hypothesis of a dif-
ference between the group means. To test the assumption of 
homogeneity of variances and normality, Student’s t-test was 
used at the 1% level (P < 0.01) alongside visual inspection of 
residuals from the mean. If age or other parameters showed a 
statistically significant difference between the two groups, an 
ANCOVA model was applied with age, or other parameters, as 
a covariate. Where the assumptions of the t-test were not met, 
the Wilcoxon rank sum test was applied. When the assump-
tions of the variables failed, the Mann-Whitney U test was 
used. The hypothesis tests were carried out with an alpha sig-
nificance level of 5% (P < 0.05). The Bonferroni adjustment 
was used to maintain this level at 5%. Each p-value related to 
the primary endpoint was compared to the 1% significance 
level (0.05 divided by number of ROIs [5]) in order to main-
tain the overall alpha significance level. In all cases where the 
sample sizes were deemed too small, no analysis was carried 
out and descriptive summaries were examined. Data analysis 
was performed with SAS version 9.1.3 (SAS Institute Inc., 
Cary, NC). 
Results
Due to the small number of cases in each group, females and 
males were evaluated together. Type 2 patients were younger 
than those with type 1 implants (p < 0.001). Anthropometric 
parameters were equally distributed in both groups. No differ-
ences in L1-L4 and total hip BMD were observed between the 
Table 1. Regions of interest (ROIs) precision error of the peripros-
thetic (operated) and contralateral (unoperated) hips
ROIs   1   2   3   4   5   Mean (SD)   Net
              average
Periprosthetic   2.8   2.1   1.9   2.7   3.4   2.6 (0.8)   2.7
Contralateral   2.5   3.7   1.5   2.6   2.4   2.5 (0.4)   2.6
Precision error is expressed as the coefficient of variation percent-
age (CV%). 294  Acta Orthopaedica 2009; 80 (3): 291–297
study groups (Table 2).
The Harris hip score improved from 43 and 47 to 95 and 96 
points at the 3-year follow-up in the type 1 and type 2 groups, 
respectively. No thigh pain was reported at any of the postop-
erative evaluations.
There were no signs of radiographic subsidence or radio-
lucent lines in any of the stems. On standard radiographic 
assessment, stem alignment appeared to be neutral in all cases. 
No heterotopic ossification was observed.
 Periprosthetic NETAVG revealed no statistically significant 
differences between the groups. In the type 2 group, higher 
absolute BMD values were observed in medial ROIs 4 (p < 
0.001) and 5 (p = 0.004). No differences were found in ROIs 
1,  2,  and  3. ANCOVA  adjusting  for  the  difference  in  age 
between the two study groups provided the same conclusion 
as the main analysis (Table 3).
 With type 1, the implant caused bone loss in all ROIs com-
pared to the contralateral hip, while in type 2 there was a gain 
in bone mass of 9.5% and 9.4% in regions 2 and 4, respec-
tively. The differences in BMD percentage changes between 
the type 1 and type 2 groups were statistically significant in 
regions 4 (p = 0.001) and 5 (p = 0.007) (Table 4).
Discussion
DXA is considered the most reliable tool to evaluate bone 
remodeling after THA using different stem designs (Albanese 
et al. 2006, Panisello et al. 2006). Analysis of the 7 peripros-
thetic Gruen zones is the most commonly used protocol to 
evaluate bone remodeling after the implantation of conven-
tional femoral stems (Aldinger et al. 2003, Bodén et al. 2006, 
Panisello et al. 2006). In our study, all DXA measurements 
were taken 3 years after THA. Biomechanical adaptation to 
the prosthesis occurs mainly within 2–3 years, until a BMD 
plateau stage is reached (Mirsky and Einhorn 1998, Venesmaa 
et al. 2001, Aldinger et al. 2003, Brodner et al. 2004, Bodén et 
al. 2006, Panisello et al. 2006). The initial postoperative BMD 
(Venesmaa et al. 2001) or the preoperative BMD value can 
be used as the baseline value to estimate the change in peri-
Table 2. General characteristics of the study population. Values are 
expressed as number or mean (SD) 
  Type 1   Type 2   p-value
Number   11  26 
Sex (M/F)   9/2   22/4 
Age, years   63 (10)   50 (8.7)   0.001
Weight, kg   73 (11)   78 (11)   0.2
Height, cm   173 (8.8)   173 (8.5)   0.9
BMI   25 (4.4)   26 (3.8)   0.4
Total hip BMD (g/cm2)  1.24 (0.10)   1.28 (0.14)   0.4
L1–L4 BMD (g/cm2)   1.32 (0.06)   1.21 (0.29)   0.5
BMI: body mass index; BMD: bone mineral density.
Table 3. BMD (g/cm2) of the 5 ROIs and BMD net average of the 
operated hips. Values are mean (SD) 
  Type 1   Type 2   (95% CI)   p-value a
  (n = 11)  (n = 26)
ROI 1   0.74 (0.07)   0.82 (0.13)   (-0.01–0.19)  0.08
ROI 2   1.21 (0.23)   1.37 (0.26)   (-0.09–0.35)  0.2
ROI 3   1.61 (0.19)   1.58 (0.19)   (-0.20–0.14)  0.7
ROI 4   1.20 (0.19)   1.57 (0.19)    (0.18–0.51)  < 0.001
ROI 5   0.92 (0.13)   1.18 (0.21)    (0.09–0.43)  0.004
Net average   1.19 (0.09)   1.27 (0.14)   (-0.04–0.19)  0.2
a ANCOVA model for between-group comparisons of BMD, with age 
as a covariate. The p-values have been compared to the significance 
level of 0.01 using the Bonferroni adjustement. 
BMD: bone mineral density; ROI: region of interest; 
Table 4. Periprosthetic BMD percentage change between operated and unoperated contralat-
eral hip of the 5 ROIs in the type 1 and type 2 groups. Values are mean (SD) or percentage (%)
  Type 1 (n = 11)   Type 2 (n = 26)   (95% CI)  p-value 
   BMD    % change    BMD    % change
  percentage    percentage
ROI 1     87 (11)   –13     96 (13)   –4.0  (-3.8–21)  0.2 a
ROI 2     88 (14)   –12  110 (20)   9.5    (2.2–39)  0.3 a
ROI 3   100 (11)   –0.39     95 (6.2)   –5.2   (-14–1.2)  0.1 a
ROI 4     91 (13)   –9.0   110 (11)   9.4    (8.7–32)  0.001 a
ROI 5     76 (9.5)   –24     93 (17)   –6.7    (1.9–32)  0.007 b
Net average     99 (9.2)   –0.64   106 (8.2)   5.6  (-3.0–14)  0.2 a
a ANCOVA model for between-group comparisons of %Contralateral, with age as a covariate.
b Mann-Whitney U test for between-group comparison of %Contralateral.
The p-values have been compared to the significance level of 0.01 using the Bonferroni adjuste-
ment.
BMD: bone mineral density; ROI: region of interest; NETAVG: net average;
BMD percentage = (BMD of operated hip / BMD of non operated hip) x 100.
% change: percentage change between operated and non operated contralateral hip. Acta Orthopaedica 2009; 80 (3): 291–297  295
prosthetic BMD (Kobayashi et al. 2000). However, in cross-
sectional studies the contralateral unoperated hip is also used 
to obtain individual comparative BMD values (Gibbons et al. 
1997, Munting et al. 1997, Aldinger et al. 2003)—as we did. 
The amount of periprosthetic bone remodeling appears to 
be influenced by different factors, including sex, age, weight, 
BMI, bone mass, and stem design. Many authors have reported 
conflicting  results  when  testing  factors  that  could  possibly 
influence the periprosthetic BMD. Brodner et al. (2004) noted 
that gender affected Gruen zones 2, 3, 4, 5, and 6. They also 
observed that BMI influenced the BMD in zone 3 (lateral 
diaphysis) while age affected the greater trochanter (zone 1) 
and zone 4. Rahmy et al. (2004) reported that although pre-
operative  BMD  was  the  most  important  factor  predicting 
bone loss after THA, stem design remains a major factor in 
influencing periprosthetic bone loss in Gruen zones 4 and 7, 
even after controlling for the effects of preoperative BMD and 
gender. Other authors (Korovessis et al. 1997, Sköldenberg et 
al. 2006) reported no correlation between age and peripros-
thetic changes in BMD while Kärrholm et al. (2002) evalu-
ated  multiple  variables  and  found  that  postoperative  BMD 
was only influenced by the stem design. In our study, type 
2 patients were younger on average than type 1 patients. No 
differences were found between the 2 study groups in terms 
of radiological pre- and postoperative bone quality, anthro-
pometrical parameters, and skeletal mineralization measured 
at the lumbar spine and contralateral proximal femur. Thus, 
the periprosthetic bone remodeling observed in these patients 
appears to be closely related to implant design rather than 
patient age.
We assessed the effect on bone remodeling of 2 metaphy-
seal implants with a design considerably different from that of 
most commercially available femoral stems. Type 1 had a very 
short stem, and type 2 had no diaphyseal stem. These prosthe-
ses were conceived and first implanted in 1995 by Santori et 
al. (2006a), the rationale of the new idea being based on the 
assumption that it is possible to achieve enough stability with-
out the diaphyseal portion of the stem provided the implant 
has a well-defined lateral flare (Santori et al. 2006a, c).
Some publications on conventional femoral implants have 
reported a correlation between femoral stem size and proximal 
bone loss (Nishii et al. 1997, Sköldenberg et al. 2006), while 
other investigators have found no such correlation (Yamagu-
chi et al. 2000, Sychterz et al. 2001). Although a number of 
previous DXA studies have investigated periprosthetic bone 
remodeling following uncemented THA, a precise compari-
son of the results is not always possible due to differences 
in stem design and protocol. Our study represents the first 
experience on the effect on BMD of progressive shortening of 
the femoral stem in a short-stemmed prosthesis, evaluated by 
DXA. Increased bone mass in the stemless implant was found 
in medial ROIs 4 and 5 and in lateral and medial regions when 
compared to the contralateral unoperated femur. In the stem-
less implant group, calcar bone loss was only 7% as compared 
to 24% loss in the short-stem group. Previous studies on BMD 
changes in conventional stems have shown substantial bone 
loss in Gruen zone 7 (calcar). In the studies by Venesmaa et al. 
(2001) and by Rosenthall et al. (1999), bone loss in zone 7 at 
the 3-year follow-up was 23% and 20%, respectively. Rahmy 
et al. (2004) reported a mean loss of 16% in patients with an 
anatomic stem and 6% in patients with a more proximal load-
ing implant. Munting et al. (1997) tested the behavior of a 
stemless femoral component and reported an increase in BMD 
in the proximal medial femoral cortex at the 3-year follow-
up. In most femurs with an initial BMD that was lower than 
that of the unoperated hip, they also observed an increase in 
BMD until the BMD values became similar on both sides. In 
an experimental study, Decking et al. (2006) measured strain 
distribution before and after insertion of 3 different kinds of 
stems  in  human  cadaveric  femora:  a  conventional  straight 
stem based on a distal anchorage concept, an anatomic stem 
designed to have proximal loading, and a “stemless” femoral 
neck prosthesis. They found a decrease in strain in the proxi-
mal femur after the insertion of both the straight and the ana-
tomic stems, and a more physiological strain distribution in 
the medial region of the hip with the stemless implant. 
An vitro study of the commercially available version that 
was developed of the type 2 prosthesis, which shares the design 
of this custom-made implant, suggested that poor bone qual-
ity, varus or valgus malpositioning, and implant undersizing, 
were important criteria that could lead to failure (Westphal et 
al. 2006). Thus, both surgical technique and careful patient 
selection appear to be crucial factors for the survivorship of 
an ultra-short implant. The positive clinical outcome observed 
in our study may be attributed to the experience of the operat-
ing surgeon. In fact, all baseline and follow-up radiographs 
showed correct alignment and sizing of the implant in both 
series. We cannot therefore evaluate the influence of potential 
varus or valgus misalignment on periprosthetic bone remod-
eling  in  such  prostheses.  However,  Panisello  et  al.  (2006) 
recently  reported  that  in  a  conventional  anatomic  implant, 
malalignment had no clinical consequences and resulted in 
minimal differences in bone remodeling. Even so, despite the 
fact that implants were well aligned in both groups, the ultra-
short implant showed better strain distribution—resulting in a 
more favorable pattern of bone remodeling in the ROIs known 
to be at high risk of bone loss. A similar finding was reported 
when this short implant was compared to different conven-
tional prosthetic designs, characterized by a long or very long 
stem (Albanese et al. 2006). 
Some limitations of this study should be considered. Because 
most subjects were men and the number of women was small, 
the effect of gender differences on bone remodeling was not 
evaluated. This work was an observational study that should 
be validated further in a prospective longitudinal trial. Single 
BMD evaluations have limited prognostic value, as the initial 
postoperative values are not known. Furthermore, use of the 
contralateral femur as a control does not necessarily account 296  Acta Orthopaedica 2009; 80 (3): 291–297
for inequality of BMD in the same patient because BMD at the 
start may not be identical in both hips. However, when data 
from time-consuming prospective studies are lacking, we have 
to use the unoperated side as a control. We believe nevertheless 
that this first report may enhance our understanding of bone 
remodeling behavior when a metaphyseal stemless prosthesis 
is implanted, and our work shows that DXA allows quantifica-
tion of the bone mass around these new femoral implants.
In conclusion, our study suggests that DXA can be adapted 
to the specific requirements of a particular implant design. We 
suggest that a 5-ROI protocol of analysis is suitable for evalu-
ation of bone remodeling after THA with stemless implants. 
Using this diagnostic technique and the 5-ROI protocol of 
analysis, we found that the ultra-short implant—which has 
a more anatomical proximal fit without having a diaphyseal 
stem  with  distal  cortical  contact—can  provide  immediate 
postoperative stability and a more physiological load distribu-
tion, thus increasing periprosthetic BMD in the medial regions 
over time. 
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